Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05291845 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 12, 2025 (before its estimated October 3, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 54 to 162v4 Show 6 more changesShow less
    • Primary completion date: Oct 3, 2023 to Oct 3, 2025
    • Trial status: Completed to Recruiting
    • Study completion date: Jan 6, 2024 to Dec 6, 2025
    • Study description revised
    • Site details revised
    • Publications: details revised at 2 of 2 entries
  2. Trial status: Recruiting to Completedv3 Show 6 more changesShow less
    • Enrollment target: estimated 75 to confirmed 54
    • Primary completion date changed from estimate of Oct 2023 to Oct 3, 2023
    • Study completion date changed from estimate of Oct 2023 to Jan 6, 2024
    • Study description revised
    • Site details revised
    • Publications: details revised at 2 of 2 entries
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2022 to Apr 3, 2022
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To follow up the efficacy and safety of Candida antigen, bivalent HPV vaccine in treatment of common warts either mono or combined intralesional therapy
Trial Details
NCT Number NCT05291845
Lead Sponsor Zagazig University
Conditions
(from sponsor)		 Warts, Human Papilloma Virus
Related terms Warts
Enrollment 162 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov